Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Multiple Sclerosis:

Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Correale J et al. Brain. (2017)

Multiple sclerosis. Nicholas R et al. Am Fam Physician. (2013)

Classification, diagnosis, and differential diagnosis of multiple sclerosis. Katz Sand I et al. Curr Opin Neurol. (2015)

Search results

Items: 1 to 20 of 85186

1.

The Sympathetic Nervous System Mitigates CNS Autoimmunity via β2-Adrenergic Receptor Signaling in Immune Cells.

Araujo LP, Maricato JT, Guereschi MG, Takenaka MC, Nascimento VM, de Melo FM, Quintana FJ, Brum PC, Basso AS.

Cell Rep. 2019 Sep 17;28(12):3120-3130.e5. doi: 10.1016/j.celrep.2019.08.042.

PMID:
31533035
2.

Inhibitory B cell co-receptors and autoimmune diseases.

Tsubata T.

Immunol Med. 2019 Sep 18:1-9. doi: 10.1080/25785826.2019.1660038. [Epub ahead of print]

PMID:
31532707
3.

The Impact of Cannabinoid Receptor 2 Deficiency on Neutrophil Recruitment and Inflammation.

Hussain MT, Greaves DR, Iqbal AJ.

DNA Cell Biol. 2019 Sep 18. doi: 10.1089/dna.2019.5024. [Epub ahead of print]

PMID:
31532239
4.

Inversion recovery UTE based volumetric myelin imaging in human brain using interleaved hybrid encoding.

Jang H, Ma Y, Searleman AC, Carl M, Corey-Bloom J, Chang EY, Du J.

Magn Reson Med. 2019 Sep 18. doi: 10.1002/mrm.27986. [Epub ahead of print]

PMID:
31532032
5.

Do maternal anti-N-methyl-D-aspartate receptor antibodies promote development of neuropsychiatric disease in children?

Pröbstel AK, Zamvil SS.

Ann Neurol. 2019 Sep 18. doi: 10.1002/ana.25584. [Epub ahead of print] No abstract available.

PMID:
31531881
6.

Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.

Guger M, Enzinger C, Leutmezer F, Kraus J, Kalcher S, Kvas E, Berger T; Austrian MS Treatment Registry (AMSTR).

J Neurol. 2019 Sep 17. doi: 10.1007/s00415-019-09535-2. [Epub ahead of print]

PMID:
31531765
7.

[Indications for varicella zoster and herpes zoster vaccination in multiple sclerosis: current situation].

Winkelmann A, Löbermann M, Zettl UK.

Nervenarzt. 2019 Sep 17. doi: 10.1007/s00115-019-00806-x. [Epub ahead of print] Review. German.

PMID:
31531686
8.

Randomized controlled trial of SystemCHANGE™ weight management intervention in neurological conditions.

Plow M, Moore SM, Chang J, Bachhal E, Sparks KE.

Patient Educ Couns. 2019 Aug 10. pii: S0738-3991(19)30323-4. doi: 10.1016/j.pec.2019.08.007. [Epub ahead of print]

PMID:
31530424
9.

Validation of the Pittsburgh Fatigability Scale in a mixed sample of adults with and without chronic conditions.

Carlozzi NE, Boileau NR, Murphy SL, Braley TJ, Kratz AL.

J Health Psychol. 2019 Sep 18:1359105319877448. doi: 10.1177/1359105319877448. [Epub ahead of print]

PMID:
31530191
10.

Management of relapsing-remitting multiple sclerosis in Qatar: an expert consensus.

Deleu D, Canibaño B, Mesraoua B, Adeli G, Abdelmoneim MS, Ali Y, Elalamy O, Melikyan G, Boshra A.

Curr Med Res Opin. 2019 Sep 18:1. doi: 10.1080/03007995.2019.1669378. [Epub ahead of print]

PMID:
31530036
11.

T-cell depleted HLA-haploidentical HSCT in a child with neuromyelitis optica.

Ceglie G, Papetti L, Figà Talamanca L, Lucarelli B, Algeri M, Gaspari S, Li Pira G, Colafati GS, Montanari M, Valeriani M, Locatelli F, Merli P.

Ann Clin Transl Neurol. 2019 Sep 17. doi: 10.1002/acn3.50843. [Epub ahead of print]

12.

Nrf2 deficiency increases oligodendrocyte loss, demyelination, neuroinflammation and axonal damage in an MS animal model.

Nellessen A, Nyamoya S, Zendedel A, Slowik A, Wruck C, Beyer C, Fragoulis A, Clarner T.

Metab Brain Dis. 2019 Sep 16. doi: 10.1007/s11011-019-00488-z. [Epub ahead of print]

PMID:
31529356
13.

Asymmetric Loss Functions and Deep Densely Connected Networks for Highly Imbalanced Medical Image Segmentation: Application to Multiple Sclerosis Lesion Detection.

Hashemi SR, Salehi SSM, Erdogmus D, Prabhu SP, Warfield SK, Gholipour A.

IEEE Access. 2019;7:721-1735. doi: 10.1109/ACCESS.2018.2886371. Epub 2018 Dec 12.

PMID:
31528523
14.

Anti-John Cunningham virus antibody index levels in multiple sclerosis patients treated with rituximab, fingolimod, and dimethyl fumarate.

Farley S, Gottesman MH, Friedman-Urevich S, Ye J, Shen M, Grueneberg D, Martone L, Calixte R.

Surg Neurol Int. 2019 Apr 24;10:59. doi: 10.25259/SNI-4-2019. eCollection 2019.

PMID:
31528397
15.

When encephalitogenic T cells collaborate with microglia in multiple sclerosis.

Dong Y, Yong VW.

Nat Rev Neurol. 2019 Sep 16. doi: 10.1038/s41582-019-0253-6. [Epub ahead of print] Review.

PMID:
31527807
16.

CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis.

Mørkholt AS, Trabjerg MS, Oklinski MKE, Bolther L, Kroese LJ, Pritchard CEJ, Huijbers IJ, Nieland JDV.

Sci Rep. 2019 Sep 16;9(1):13299. doi: 10.1038/s41598-019-49868-6.

17.

Pleiotropic requirements for human TDP-43 in the regulation of cell and organelle homeostasis.

Roczniak-Ferguson A, Ferguson SM.

Life Sci Alliance. 2019 Sep 16;2(5). pii: e201900358. doi: 10.26508/lsa.201900358. Print 2019 Oct.

18.

The association between executive functioning, coping styles and depressive symptoms in patients with Multiple Sclerosis.

Van Heugten C, Köhler S, Francke M, Bol Y.

Mult Scler Relat Disord. 2019 Sep 9;36:101392. doi: 10.1016/j.msard.2019.101392. [Epub ahead of print]

PMID:
31526983
19.

Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients.

Kürtüncü M, Yılmaz V, Akçay Hİ, Türkoğlu R, Altunrende B, Çınar SA, Ulusoy C, Gündüz T, İçöz S, Kasap M, Çalışkan Z, Ötünç G, Eraksoy M, Tüzün E.

J Neuroimmunol. 2019 Sep 11;337:577065. doi: 10.1016/j.jneuroim.2019.577065. [Epub ahead of print]

PMID:
31526917
20.

Comparison of Copaxone® and Synthon's therapeutically equivalent glatiramer acetate.

Arends RJ, Wang D, Buurman M, Luten J, Koper NP, Wolf C, Scheren M.

Pharmazie. 2019 Aug 1;74(8):449-461. doi: 10.1691/ph.2019.9515.

PMID:
31526436

Supplemental Content

Loading ...
Support Center